30-Oct-2026 20:29:36
SUDARSHANGeneral news
SUDARSHAN : PREFERENTIAL WARRANT ISSUE WORTH UP TO RS 72 CR
• Board approved issue of convertible warrants up to ₹72 Cr on preferential basis to promoters Mr. Hemal Mehta and Mr. Sachin Mehta • Each warrant convertible into 1 equity share of face value Re 1 • Warrant issue price to be determined as per Regulation 164 of SEBI ICDR Regulations • Subject to regulatory/statutory approvals and shareholders' approval at an EGM
Sudarshan Pharma Industries Ltd
Open attachment